PAOG Announces Acquisition of Resprx Entering $200B Biopharma Market

Sandusky, Ohio–(Newsfile Corp. – July 30, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today announced the acquisition of RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). Figure 1: RespRxTo view an enhanced version of Figure 1, please visit:https://orders.newsfilecorp.com/files/6729/60840_1e8cf574f43778a3_001full.jpgRespRx is a treatment for Chronic Obstructive Pulmonary Disease (COPD) under development that is derived from a patented cannabis extraction method – U.S.…

Read More